No products in the basket.
Elixi Heartbene® Blueberry 300g
For controlling blood pressure and reducing cholesterol
Elixi Heartbene is a patented mixture of Finnish crushed flaxseed, plant sterol and potassium and calcium salts. Elixi Heartbene helps the blood pressure to remain normal* and reduces the cholesterol level of the blood**. Elixi Heartbene is intended as a part of a varied diet. The product is gluten-free.
*Potassium helps the blood pressure to remain normal. **Plant sterols have been shown to reduce blood cholesterol. A high level of cholesterol is a risk factor in the development of coronary disease. The beneficial effect of plant sterols on the cholesterol level of the blood can be gained by consuming 1.5 g – 2.4 g of plant sterols on a daily basis. The daily dose (10 g) contains 1.8 g of plant sterol.
Elixi Heartbene is available on Amazon!
Product details
Average nutritional values | Dose (10 g) |
---|---|
Energy | 173,5 kj / 41,9 kcal |
Fat, of which | 1,20 g |
Saturated fatty acids | 0,33 g |
Monounsaturated fatty acids | 0,08 g |
Polyunsaturated fatty acids | 1,09 g |
Carbohydrates | 0,4 g |
of which sugars | 0,2 g |
Dietary fibers | 2,2 g |
of which lignan | 0,04 g |
Protein | 1,74 g |
Salt | 0 g |
Potassium | 500 mg (25 % *) |
Calsium | 250 mg (31 % *) |
Magnesium | 30 mg (8 %*) |
Plant sterols | 1,80 g |
*) of the daily intake reference value
GLUTEN-FREE
Recommended usage:
Elixi Heartbene is recommended for use with breakfast or a snack, for example mixed into yogurt, porridge or a smoothie.
Recommended daily dose:
2 measures, i.e. a total of 10 g/day.
Ingredients:
Crushed flaxseed, plant sterol, potassium citrate, calcium citrate and blueberry powder.
Storage:
In a dry place, at room temperature and away from sunlight.
—
The product is not recommended for women who are pregnant or breastfeeding.
A dietary supplement is no substitute for a varied and balanced dietor a healthy lifestyle.
Keep out of the reach of children.
Do not exceed the stated recommended daily dose.
Reviews
There are no reviews yet.